Sasha Stanton, MD, discusses efforts to improve the responses to immunotherapy regimens in early-stage hormone receptor–positive breast cancer.
Sasha Stanton, MD
Advertisement
Articles by Sasha Stanton, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
2
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
3
Aglatimagene Besadenovec Plus EBRT Improves Prostate Cancer-Specific DFS
4
Hematologists Highlight Top Data From ASCO 2026
5